Short Interest in Celularity Inc. (NASDAQ:CELUW) Rises By 628.4%

Celularity Inc. (NASDAQ:CELUW) saw a large increase in short interest in May. As of May 15th, there was short interest totaling 24,342 shares, an increase of 628.4% from the April 30th total of 3,342 shares. Based on an average daily volume of 16,940 shares, the short-interest ratio is currently 1.4 days.

Celularity Stock Up 25.5%

Shares of CELUW stock traded up $0.00 during mid-day trading on Friday, reaching $0.01. 100 shares of the company were exchanged, compared to its average volume of 18,071. Celularity has a fifty-two week low of $0.01 and a fifty-two week high of $0.07. The business’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.